Surgical management of malignant pleural mesothelioma: a systematic review and evidence summary

被引:71
作者
Maziak, DE
Gagliardi, A
Haynes, AE
Mackay, JA
Evans, WK
机构
[1] Univ Ottawa, Ottawa Hosp, Ottawa, ON K1H 8L6, Canada
[2] Canc Care Ontario, Surg Oncol Network, Toronto, ON M5G 2L7, Canada
[3] McMaster Univ, Canc Care Ontario Program Evidence Based Care, Hamilton, ON L8S 4L8, Canada
[4] Canc Care Ontario, Juravinski Canc Ctr Hamilton Hlth Sci, Hamilton, ON L8V 5C2, Canada
关键词
pleural mesothelioma; pleurectomy; extrapteural pneumonectomy; systematic review;
D O I
10.1016/j.lungcan.2004.11.003
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
An evidence summary was developed for the surgical management of adult patients with diffuse or localized malignant pleural mesothelioma. This evidence summary is based on a systematic search and review of the literature published between 1985 and February 2004. Relevant studies were identified, according to pre-determined criteria by the authors and methodologists. No randomized controlled trials comparing pleurectomy (PL) with extrapleural pneumonectomy (EPP) or comparing surgery with an alternative treatment were identified. Four comparative studies, seven non-comparative prospective studies, and 16 retrospective case series were identified that looked at PL, or EPP, or PL and EPP. Trial results were not pooled due to the heterogeneity of the treatments in the trials and the fact that no trials were randomized and none were designed to directly compare different treatments. External feedback was obtained from Ontario clinicians, and the provincial Lung Cancer Disease Site Group approved the review. Conclusions: The role of surgery in the management of malignant pleural mesothelioma cannot be precisely defined as the lack of randomized controlled clinical trials makes it impossible to determine whether the use of EPP or PL improves survival or effectively palliates the symptoms of the disease. Future studies of the role of surgery in the treatment of mesothelioma should include evaluations of quality of Life. (c) 2004 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:157 / 169
页数:13
相关论文
共 41 条
[1]  
Achatzy R, 1989, Eur J Cardiothorac Surg, V3, P445, DOI 10.1016/1010-7940(89)90056-0
[2]   MALIGNANT PLEURAL MESOTHELIOMA - A DISEASE UNAFFECTED BY CURRENT THERAPEUTIC MANEUVERS [J].
ALBERTS, AS ;
FALKSON, G ;
GOEDHALS, L ;
VOROBIOF, DA ;
VANDERMERWE, CA .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (03) :527-535
[3]  
Allen K B, 1994, Chest Surg Clin N Am, V4, P113
[4]   MALIGNANT MESOTHELIOMA - PROGNOSTIC VARIABLES IN A REGISTRY OF 180 PATIENTS, THE DANA-FARBER-CANCER-INSTITUTE AND BRIGHAM-AND-WOMENS-HOSPITAL EXPERIENCE OVER 2 DECADES, 1965-1985 [J].
ANTMAN, K ;
SHEMIN, R ;
RYAN, L ;
KLEGAR, K ;
OSTEEN, R ;
HERMAN, T ;
LEDERMAN, G ;
CORSON, J .
JOURNAL OF CLINICAL ONCOLOGY, 1988, 6 (01) :147-153
[5]   The management of malignant pleural mesothelioma; single centre experience in 10 years [J].
Aziz, T ;
Jilaihawi, A ;
Prakash, D .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2002, 22 (02) :298-305
[6]  
*B C CANC AG, TYP CANC MES
[7]  
BELL DL, 1990, AM J CLIN ONCOL-CANC, V13, P4
[8]   PLEURECTOMY FOR MESOTHELIOMA [J].
BRANCATISANO, RP ;
JOSEPH, MG ;
MCCAUGHAN, BC .
MEDICAL JOURNAL OF AUSTRALIA, 1991, 154 (07) :455-&
[9]   DIAGNOSTIC AND THERAPEUTIC STRATEGY IN MALIGNANT PLEURAL MESOTHELIOMA [J].
BRANSCHEID, D ;
KRYSA, S ;
BAUER, E ;
BULZEBRUCK, H ;
SCHIRREN, J .
EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 1991, 5 (09) :466-473
[10]   THE PRACTICE GUIDELINES DEVELOPMENT CYCLE - A CONCEPTUAL TOOL FOR PRACTICE GUIDELINES DEVELOPMENT AND IMPLEMENTATION [J].
BROWMAN, GP ;
LEVINE, MN ;
MOHIDE, EA ;
HAYWARD, RSA ;
PRITCHARD, KI ;
GAFNI, A ;
LAUPACIS, A .
JOURNAL OF CLINICAL ONCOLOGY, 1995, 13 (02) :502-512